🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Rossari Biotech Limited ROSSARI NSEINFRA

Basic Materials · Specialty Chemicals · India
https://www.rossari.com
Company Profile ↓
₹532.10
-23.98% 1Y
Mkt Cap₹2,946.95 Cr
P/E21.60
P/B2.20
Div. Yield0.10%
52W High₹742.58
52W Low₹378.24
Book Value₹240.75
EPS (TTM)₹24.63

Company Overview

Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers home, personal care, and performance chemicals products, such as soaps and detergents; oil and gas division; inks; paints and coatings; ceramics and tiles; pulp and paper; cement; water treatment; performance additives; cleaning, hygiene, and disinfection; surfactants; and textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions. The company also provides pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, and creams; and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in Mumbai, India.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 15.4%.

Consistent Profit Growth

Net profit has compounded at 11.6% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 13.1% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 21.6, below the sector median of 27.4.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.33.

Recent Developments

  • Mar 2026 Revenue of ₹2,389.82 Cr (+15.4% YoY); net profit ₹149.21 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +15.4%, earnings +9.4%.
  • 5-Year Trend Long-term compounding — revenue CAGR 13.1%, profit CAGR 11.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:13.11%
1 Year:15.37%

Compounded Profit Growth

5 Years:11.63%
1 Year:9.41%

Stock Price Performance

1 Year:-23.98%
6 Months:-3.64%
3 Months:+5.62%
1 Month:+3.72%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 42% of range
₹378.24 ₹742.58
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)54.30 · Neutral
Price Performance
1M+3.72%
3M+5.62%
6M-3.64%
1Y-23.98%
Valuation vs Sector

P/E of 21.60 is below the sector median of 27.45 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 13.1% over 5 years.
  • Profit CAGR of 11.6% over 5 years.

CONS

  • Trading 28.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
21.60
Industry PE
27.45
Forward P/E
15.86
PEG Ratio
-
Book Value
₹240.75
Price to Book
2.20
P/S
1.22
EV/EBITDA
12.48
Dividend Yield
0.10%

Growth (CAGR)

Revenue 5Y
13.11%
Profit 5Y
11.63%
Revenue (YoY)
15.37%
Earnings (YoY)
9.41%

Profitability & Returns

ROCE
15.41%
ROE
11.19%
ROA
6.52%
Profit Margin
6.24%
Op Margin
7.95%
Gross Margin
29.53%
EPS (Latest Qtr)
₹8.29
EPS (TTM)
₹24.63

Balance Sheet & Liquidity

Debt/Equity
0.33
Quick Ratio
1.05
Current Ratio
1.57
Debt
₹435.94 Cr
Total Assets
₹2,288.79 Cr
Current Assets
₹1,235.90 Cr
Working Capital
₹446.34 Cr

Ownership

Promoter Holding
68.14%
Chg in Prom Hold
-0.01%
FII / Inst Holding
18.61%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
₹2,946.95 Cr
Total Revenue (TTM)
₹2,389.82 Cr
EBITDA
₹310.18 Cr
Free Cash Flow
₹-199.60 Cr
Operating Cash Flow
₹65.07 Cr
Shares Outstanding
₹5.54 Cr
Gross Margin
29.53%
Payout Ratio
1.86%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ROSSARI Rossari Biotech Limited NSEINFRA 532.10 21.60 ₹2,946.95 Cr 0.10% 15.41% 11.19% 13.11% 11.63%
2 ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA 11,659.00 56.84 ₹3.44 L Cr 0.66% 11.90% 10.66% 12.40% 17.26%
3 JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA 1,244.70 86.92 ₹3.04 L Cr 0.57% 18.75% 22.30% 3.61% 75.28%
4 ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA 2,675.50 59.31 ₹2.57 L Cr 1.03% 24.41% 20.24% 1.10% 1.75%
5 TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA 187.67 21.70 ₹2.34 L Cr 2.09% 11.32% 10.56% -1.59% 7.21%
6 HINDZINC Hindustan Zinc Limited NSEINFRA 532.50 16.26 ₹2.25 L Cr 3.91% 61.97% 61.13% 5.61% 9.58%
7 HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA 963.55 16.01 ₹2.17 L Cr 0.52% 9.42% 9.80% 7.10% 9.87%
8 GRASIM Grasim Industries Limited NIFTY50NSEINFRA 3,133.10 56.45 ₹2.13 L Cr 0.31% 4.00% 4.80% 14.63% -10.06%
9 VAML Vedanta Aluminium Metal Limited NSEINFRA 452.95 inf ₹1.77 L Cr 0.00% 41.97% 49.39% - -46.32%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 406.00 Cr411.00 Cr483.00 Cr464.00 Cr473.00 Cr490.00 Cr498.00 Cr512.73 Cr579.56 Cr543.72 Cr586.00 Cr581.68 Cr684.86 Cr
Cost of Revenue -------350.05 Cr401.65 Cr371.35 Cr-400.80 Cr495.72 Cr
Gross Profit -------162.68 Cr177.91 Cr172.37 Cr-180.88 Cr189.14 Cr
Operating Expenses 352.00 Cr353.00 Cr420.00 Cr400.00 Cr409.00 Cr425.00 Cr432.00 Cr116.24 Cr126.64 Cr122.26 Cr514.00 Cr131.62 Cr135.42 Cr
Operating Income 39.00 Cr44.00 Cr49.00 Cr49.00 Cr48.00 Cr50.00 Cr51.00 Cr46.44 Cr51.27 Cr50.11 Cr54.00 Cr49.26 Cr53.72 Cr
EBITDA 55.00 Cr58.00 Cr64.00 Cr64.00 Cr64.00 Cr65.00 Cr66.00 Cr65.64 Cr71.43 Cr69.58 Cr72.00 Cr69.78 Cr96.83 Cr
Interest Expense 4.00 Cr6.00 Cr5.00 Cr4.00 Cr3.00 Cr4.00 Cr4.00 Cr4.94 Cr5.50 Cr5.73 Cr6.00 Cr7.67 Cr9.06 Cr
Pretax Income 37.00 Cr39.00 Cr45.00 Cr48.00 Cr46.00 Cr47.00 Cr48.00 Cr42.38 Cr47.71 Cr46.10 Cr50.00 Cr42.50 Cr64.24 Cr
Tax Provision 8.14 Cr10.14 Cr11.70 Cr13.44 Cr11.50 Cr12.22 Cr12.96 Cr10.68 Cr13.26 Cr12.50 Cr13.00 Cr9.73 Cr18.28 Cr
Net Income 29.00 Cr29.00 Cr33.00 Cr34.00 Cr34.00 Cr35.00 Cr35.00 Cr31.70 Cr34.44 Cr33.60 Cr37.00 Cr32.77 Cr45.97 Cr
Diluted EPS 5.255.305.976.236.186.326.395.726.216.066.665.918.29

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 516.00 Cr600.00 Cr709.00 Cr-1,651.32 Cr1,825.19 Cr2,071.46 Cr2,389.82 Cr
Cost of Revenue ----1,178.46 Cr1,304.07 Cr1,449.56 Cr1,684.14 Cr
Gross Profit ----472.86 Cr521.12 Cr621.90 Cr705.68 Cr
Operating Expenses 438.00 Cr495.00 Cr586.00 Cr-321.23 Cr338.40 Cr434.45 Cr515.72 Cr
Operating Income 66.00 Cr88.00 Cr101.00 Cr-151.63 Cr182.72 Cr187.45 Cr189.96 Cr
EBITDA 78.00 Cr105.00 Cr124.00 Cr-229.47 Cr257.38 Cr270.07 Cr310.18 Cr
Interest Expense 3.00 Cr4.00 Cr3.00 Cr-22.32 Cr19.37 Cr17.81 Cr28.54 Cr
Pretax Income 63.00 Cr88.00 Cr107.00 Cr-144.22 Cr177.62 Cr185.19 Cr202.51 Cr
Tax Provision 17.64 Cr22.88 Cr26.75 Cr-36.96 Cr46.93 Cr48.81 Cr53.30 Cr
Net Income 46.00 Cr65.00 Cr80.00 Cr-107.26 Cr130.69 Cr136.38 Cr149.21 Cr
Diluted EPS 103.8212.8615.4517.7019.3823.6224.63-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 250.00 Cr471.00 Cr561.00 Cr-1,367.57 Cr1,572.15 Cr1,896.18 Cr2,288.79 Cr
Current Assets ----720.21 Cr843.58 Cr1,041.93 Cr1,235.90 Cr
Cash & Equivalents ----69.20 Cr25.17 Cr44.20 Cr75.31 Cr
Inventory ----188.48 Cr282.33 Cr355.08 Cr404.55 Cr
Receivables ----353.66 Cr425.13 Cr474.50 Cr557.41 Cr
Total Liabilities ----452.40 Cr524.42 Cr710.74 Cr955.44 Cr
Current Liabilities ----348.51 Cr424.74 Cr536.57 Cr789.56 Cr
Long Term Debt ----34.93 Cr33.32 Cr100.03 Cr94.33 Cr
Total Debt 8.00 Cr67.00 Cr0-73.93 Cr118.79 Cr218.00 Cr435.94 Cr
Total Equity 123.00 Cr287.00 Cr408.00 Cr-915.17 Cr1,047.73 Cr1,185.45 Cr1,333.35 Cr
Shares Outstanding ----5.52 Cr5.52 Cr5.54 Cr5.54 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 71.00 Cr57.00 Cr48.00 Cr-151.56 Cr43.26 Cr137.44 Cr65.07 Cr
Investing Cash Flow -37.00 Cr-190.00 Cr-37.00 Cr--180.89 Cr-103.21 Cr-183.69 Cr-219.48 Cr
Financing Cash Flow -29.00 Cr157.00 Cr-25.00 Cr-60.85 Cr16.18 Cr64.90 Cr186.32 Cr
Capital Expenditure -44.00 Cr-76.00 Cr-56.00 Cr--32.88 Cr-131.28 Cr-158.51 Cr-264.67 Cr
Free Cash Flow 27.00 Cr-19.00 Cr-8.00 Cr-118.68 Cr-88.03 Cr-21.07 Cr-199.60 Cr
Net Change in Cash 5.00 Cr23.00 Cr-14.00 Cr-31.52 Cr-43.77 Cr18.65 Cr31.91 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ----28.6%28.6%30.0%29.5%
Operating Margin % 12.8%14.7%14.2%-9.2%10.0%9.0%7.9%
Net Margin % 8.9%10.8%11.3%-6.5%7.2%6.6%6.2%
ROE % 37.4%22.6%19.6%-11.7%12.5%11.5%11.2%
ROCE % ----14.9%15.9%13.8%12.7%

Shareholding Pattern

Insiders
68.14%
Institutions
18.61%
Public Float
58.41%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ROSSARI

Google News Mon, 04 May 2026

Rossari Biotech's (NSE:ROSSARI) Profits Appear To Have Quality Issues - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOX0V1UWdQM1JFNnpJWlp3V0RmMnVLSFRZUTU4eTg0Z3lGal9sMlFDbURYRWZCTFpyNkpSemtrWE9Xam1QX0NHUkk4N2RFdTd2TFJyU0NEX01qQ0l4RlotNklEeWRUQ2I5MFUtUFFPNUlELWMwSDJrOFVkc0JFTnZzcVltSW1tdmliOU4wT0…

Google News Mon, 29 Jun 2026

Rossari Biotech fixes record date for FY26 dividend of Re. 0.50 - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOZUJvWWtNclREaWNRS0h2dDdCSHBtSlVSek5Gd0tLcXV2eDdaVDlfbVhjcERyeVg2SW8ydkpFMHczQk5JemtEM2lCRE9XYmQwLVkxNmJ0VU5CMVllb2xDWnEzOThydG9sWW5MM0FNdFNZS0lXbGZVdHZydFVwdm1PMWtpaWFtdG5XN3kycl…

Google News Wed, 29 Apr 2026

Buy Rossari Biotech; target of Rs 570: ICICI Direct - Moneycontrol.com

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOTGh4WUQ5VjlqVUR6SUlza3l4bW5GYlhsRnVScFhQdVRsTjVWYWFieUFzUHBqU2JpdmNONl9QNEw5b0pYNUtxU210bEowY3hIMmJfYU1ZOHh0TUpoVWg5WGExeEtrcTR3RlNXZFVVMW00ZWR2cWo0eUtzb2I0XzBoVVRfcDRhd21tVHNHYW…

Google News Mon, 27 Apr 2026

Rossari Biotech Q4 profit rises 33% on higher revenue, steady margins; dividend declared - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxOWkVqd19SSkg0MG83TUswVEk0d3VzM3ZQTmNfNkpKQjV5aVlHUGpWVlRrRS03NUdnSW96eTdsdjlkMnhnMzItWjlNa2VQc3B4MEczU0NNaFdBLWRwaV9oc1NsQXFFWDBoZFY2cmkyUWZ0V0VEaEtwdzhPUi10cm5QRlZfcDZvVHJ0SlQ1dT…

Google News hu, 22 Jan 2026

Analysts Have Lowered Expectations For Rossari Biotech Limited (NSE:ROSSARI) After Its Latest Results - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNSkNhcGx1LXM3b2h6TUpDbUlzVUVWWFE4czZ5YzBvT0RDVk9XZTQ2cmNHVkxiVFMxZENLa0tpTFFsbTViT1dGbEFkald3bmd6UXM5R0EtbnBRSUpBdFFXck9wZGkyN3V5SThqNy1FS01TWjlTSzI0SHFvT21ZNVl2VFdYbTdLRVpzRGtNc2…

Google News Mon, 08 Dec 2025

5 Smallcap Specialty Chemical Stocks to Add to Your 2026 Watchlist - Equitymaster

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPS01UNS1KX2loeVNaakY5Q2xCbkJpcWIzb0ZfQUJuMjJDMWJLRGJBM0hFbUd1N3lJeGJBdHdEWGJYZ2hrRFppdVpleS1TcGozRnJaX0VWUXQ0dHVoSUJ1TERwb1FDdnRtZWtwT0diTXN1S0VUcmNaa3k3VF9HQUdTOGtFTEg5WDJJNjJ1bX…

ROSSARI — Frequently Asked Questions

What is the current share price of Rossari Biotech Limited (ROSSARI)?

As of 2026-07-15 09:52 IST, Rossari Biotech Limited (ROSSARI) trades at ₹532.10 on NSE. Its 52-week range is ₹378.24 to ₹742.58.

What is the market capitalisation of ROSSARI?

Rossari Biotech Limited (ROSSARI) has a market capitalisation of ₹2,946.95 Cr on NSE.

What is the P/E ratio of ROSSARI?

ROSSARI trades at a trailing price-to-earnings (P/E) ratio of 21.60. The industry average P/E is 27.45. Its price-to-book (P/B) ratio is 2.20.

Does ROSSARI pay a dividend?

Rossari Biotech Limited (ROSSARI) currently offers a dividend yield of 0.10%.

What is the return on equity (ROE) of ROSSARI?

ROSSARI has a return on equity (ROE) of 11.19%. Its return on capital employed (ROCE) is 15.41%.

Is ROSSARI a good stock to buy?

This page provides a data-driven analysis of Rossari Biotech Limited (ROSSARI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space